Michelle Schneider
About Michelle Schneider
Michelle Schneider serves as the Executive Director of Finance at Nektar Therapeutics, a position she has held since 2006. She has a background in corporate accounting and audit services, having previously worked at Stanford University, Franklin Templeton, and Arthur Andersen.
Current Role at Nektar Therapeutics
Michelle Schneider serves as the Executive Director of Finance at Nektar Therapeutics. She has held this position since 2006, contributing to the company's financial strategies and operations for 18 years. Her role involves overseeing financial planning, analysis, and reporting, ensuring that the organization meets its financial objectives.
Previous Experience at Stanford University
Before joining Nektar Therapeutics, Michelle Schneider worked at Stanford University as the Senior Housing Programs Associate from 2003 to 2006. In this role, she was involved in managing housing programs, contributing to the university's operational efficiency during her three-year tenure in Stanford, California.
Career at Franklin Templeton
Michelle Schneider was employed at Franklin Templeton as the Manager of Corporate Accounting from 2002 to 2003. During her one-year tenure in San Mateo, California, she managed corporate accounting functions, playing a key role in financial reporting and compliance.
Experience at Arthur Andersen
Michelle Schneider worked at Arthur Andersen as the Manager of Audit and Business Advisory Services from 1996 to 2002. Over her six years in the San Francisco Bay Area, she provided audit and advisory services to various clients, enhancing her expertise in financial management and compliance.
Education and Academic Background
Michelle Schneider studied at the University of San Francisco. Her educational background has provided her with a solid foundation in finance and accounting, which has supported her career in various financial roles across different organizations.